Heart Failure 2018 & World Congress on Acute Heart Failure

26 - 29 May 2018, Vienna - Austria

Session Details

Late breaking trial II - Chronic heart failure
Sun 27 May 08:30 - 10:00 Chronic Heart Failure Special Session, Mobile App - Ask a Question Vienna -
Chairpersons: Eugene BRAUNWALD (Boston, United States of America), Frank RUSCHITZKA (Zurich, Switzerland)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
08:30670The HF-Wii study: Improving exercise capacity of patients with heart failure through exergaming: Secondary outcomes and per protocol analysis of an international multicenter RCT Tiny JAARSMA (Norrkoping, Sweden)
08:40671Discussion - HF-WiiLoreena HILL (Co.Antrim, GB)
08:45672Diabetes and obesity in heart failure: a crossroads for prognosis and the efficacy of beta-blockersDipak KOTECHA (Birmingham, United Kingdom)
08:55673Discussion - BB-meta-HFPetar SEFEROVIC (Belgrade, RS)
09:00674Phase ii trial of pharmacogenetic guided beta-blocker therapy with bucindolol vs. metoprolol for the prevention of atrial fibrillation/flutter in heart failure: GENETIC-AFWilliam ABRAHAM (Columbus, United States of America)
09:10675Discussion - GENETIC-AFChristopher O'CONNOR (Durham, US)
09:15676Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure and a left ventricular assist deviceAlexander LYON (London, United Kingdom)
09:25677Discussion - SERCA-LVAD TRIALMaria G CRESPO-LEIRO (La Coruna, ES)
09:30678Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort Gianluigi SAVARESE (Stockholm, Sweden)
09:40679Discussion - RASi in elderly patients with HFrEFWilfried MULLENS (Genk, BE)
09:45680Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysisMichel KOMAJDA (Paris, France)
09:55681Discussion - Therapies for HFrEF: network meta-analysisMitja LAINSCAK (Murska Sobota, SI)